ANI Pharmaceuticals
ANIP
#4819
Rank
S$2.37 B
Marketcap
S$105.97
Share price
-1.17%
Change (1 day)
41.39%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.80 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is S$0.80 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.84 B124.85%
2023-12-31S$0.37 B-1.78%
2022-12-31S$0.38 B-1.13%
2021-12-31S$0.38 B58.15%
2020-12-31S$0.24 B-1.91%
2019-12-31S$0.25 B0.16%
2018-12-31S$0.25 B-7.23%
2017-12-31S$0.26 B54.36%
2016-12-31S$0.17 B8.83%
2015-12-31S$0.16 B13.97%
2014-12-31S$0.14 B
2013-12-31N/A-100%
2012-12-31S$9.64 M-57.06%
2011-12-31S$22.45 M-6.02%
2010-12-31S$23.89 M2.05%
2009-12-31S$23.41 M
2000-12-31S$0.86 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
S$7.03 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
S$6.64 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.12 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
S$78.85 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
S$0.82 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$3.39 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$11.70 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.49 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
S$11.59 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK